Abstract
Vulvovaginal candidiasis is a common condition that will, at some point, affect three-quarters of all women of reproductive age. It is caused by an overgrowth of Candida yeast. There are a number of situations that make candidiasis more likely, including pregnancy, diabetes, immunosuppression and use of antibiotics. Although many women self-medicate for mild flare-ups, they may seek the help of their GP if symptoms are severe or recurrent. This article aims to review the current evidence in investigating and managing vulvovaginal candidiasis.
| Original language | English |
|---|---|
| Pages (from-to) | 643-651 |
| Number of pages | 9 |
| Journal | InnovAiT |
| Volume | 6 |
| Issue number | 10 |
| Early online date | 12 Sept 2013 |
| DOIs | |
| Publication status | Published - Oct 2013 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Vulvovaginal candidiasis'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver